A. Schweitzer, J. Horn, R. Mikolaiczyk, G. Krause, and J. Ott, Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013, The Lancet, vol.386, issue.10003, pp.1546-1555, 2015.
DOI : 10.1016/S0140-6736(15)61412-X

J. Stanaway, A. Flaxman, M. Naghavi, C. Fitzmaurice, T. Vos et al., The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013, The Lancet, vol.388, issue.10049, pp.1081-88, 2016.
DOI : 10.1016/S0140-6736(16)30579-7

J. Garson, P. Grant, U. Ayliffe, R. Ferns, and R. Tedder, Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control, Journal of Virological Methods, vol.126, issue.1-2, pp.207-220, 2005.
DOI : 10.1016/j.jviromet.2005.03.001
URL : http://discovery.ucl.ac.uk/385/1/revised_j-vir-meth-garson-hbv-pcr.pdf

M. Rozanov, U. Plikat, C. Chappey, A. Kochergin, and T. Tatusova, A web-based genotyping resource for viral sequences, Nucleic Acids Research, vol.32, issue.Web Server, pp.654-659, 2004.
DOI : 10.1093/nar/gkh419
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC441557

S. Diop, L. Fortes-déguénonvo, M. Seydi, A. Dieng, C. Basse et al., Efficacy and tolerance of tenofovir-lamivudine-efavirenz combination in HIV-1 patients in Fann Teaching Hospital in Dakar, Bull Soc Pathol Exot, vol.2013, issue.1061, pp.22-28, 2012.

A. Lok, C. Lai, N. Leung, G. Yao, Z. Cui et al., Long-term safety of lamivudine treatment in patients with chronic hepatitis B, Gastroenterology, vol.125, issue.6, pp.1714-1722
DOI : 10.1053/j.gastro.2003.09.033

B. Stewart, M. Jobarteh, R. Sarge-njie, A. Alabi, T. De-silva et al., Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa, BMC Research Notes, vol.4, issue.1, pp.561-22195774, 2011.
DOI : 10.1186/1743-422X-5-49

A. Stockdale, R. Phillips, A. Beloukas, L. Appiah, D. Chadwick et al., Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana, Clinical Infectious Diseases, vol.61, issue.6, pp.61883-91, 2015.
DOI : 10.1093/cid/civ421

A. Boyd, R. Moh, D. Gabillard, J. Le-carrou, C. Danel et al., Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV co-infected patients from C??te d???Ivoire, Antiviral Therapy, vol.20, issue.6, pp.643-54, 2015.
DOI : 10.3851/IMP2959

L. Stabinski, S. Reynolds, P. Ocama, O. Laeyendecker, A. Ndyanabo et al., High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda, Antiviral Therapy, vol.16, issue.3, pp.405-416, 2011.
DOI : 10.3851/IMP1783

C. Hawkins, O. Agbaji, P. Ugoagwu, C. Thio, M. Auwal et al., Assessment of Liver Fibrosis by Transient Elastography in Patients With HIV and Hepatitis B Virus Coinfection in Nigeria, Clinical Infectious Diseases, vol.57, issue.12, pp.189-92, 2013.
DOI : 10.1093/cid/cit564

M. Vinikoor, L. Mulenga, A. Siyunda, K. Musukuma, R. Chilengi et al., Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia, Tropical Medicine & International Health, vol.65, issue.11, pp.1435-1441, 2016.
DOI : 10.1136/gutjnl-2015-309260

A. Ramírez-mena, T. Glass, A. Winter, N. Kimera, A. Ntamatungiro et al., Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort, Open Forum Infectious Diseases, vol.3, issue.3, 2016.
DOI : 10.1093/ofid/ofw162

S. Gitau, S. Vinayak, M. Silaba, R. Adam, and R. Shah, High Prevalence of Liver Fibrosis in Patients with Human Immunodeficiency Virus Monoinfection and Human Immunodeficiency Virus Hepatitis-B Co-infection as Assessed by Shear Wave Elastography: Study at a Teaching Hospital in Kenya, Journal of Clinical Imaging Science, vol.6, issue.1, pp.22-27403400, 2016.
DOI : 10.4103/2156-7514.183582

M. Vinikoor, E. Sinkala, A. Mweemba, A. Zanolini, L. Mulenga et al., Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia, Liver International, vol.21, issue.7, pp.1886-1892, 2015.
DOI : 10.1016/S0168-8278(05)80319-8
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478217

A. Boyd, J. Bottero, P. Miailhes, C. Lascoux-combe, H. Rougier et al., Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV???HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study, Journal of the International AIDS Society, vol.20, issue.1, p.21426, 2017.
DOI : 10.7448/IAS.20.1.21426
URL : https://hal.archives-ouvertes.fr/hal-01502149

A. Johannessen and M. Lemoine, Is aspartate aminotransferase-to-platelet ratio index a reliable tool in human immunodeficiency virus patients in Africa?, Liver International, vol.35, issue.8, p.25646656, 2015.
DOI : 10.1111/liv.12793